全文获取类型
收费全文 | 69290篇 |
免费 | 4965篇 |
国内免费 | 2627篇 |
专业分类
耳鼻咽喉 | 595篇 |
儿科学 | 1471篇 |
妇产科学 | 1534篇 |
基础医学 | 8185篇 |
口腔科学 | 1229篇 |
临床医学 | 7019篇 |
内科学 | 14724篇 |
皮肤病学 | 990篇 |
神经病学 | 5464篇 |
特种医学 | 2429篇 |
外国民族医学 | 17篇 |
外科学 | 8752篇 |
综合类 | 5457篇 |
现状与发展 | 7篇 |
一般理论 | 3篇 |
预防医学 | 3822篇 |
眼科学 | 1152篇 |
药学 | 6313篇 |
21篇 | |
中国医学 | 1956篇 |
肿瘤学 | 5742篇 |
出版年
2023年 | 649篇 |
2022年 | 1766篇 |
2021年 | 2597篇 |
2020年 | 1802篇 |
2019年 | 1765篇 |
2018年 | 2011篇 |
2017年 | 1678篇 |
2016年 | 1709篇 |
2015年 | 2314篇 |
2014年 | 3032篇 |
2013年 | 3218篇 |
2012年 | 4523篇 |
2011年 | 4597篇 |
2010年 | 2748篇 |
2009年 | 2440篇 |
2008年 | 3654篇 |
2007年 | 3670篇 |
2006年 | 3478篇 |
2005年 | 3463篇 |
2004年 | 2741篇 |
2003年 | 2479篇 |
2002年 | 2217篇 |
2001年 | 1998篇 |
2000年 | 2036篇 |
1999年 | 1958篇 |
1998年 | 898篇 |
1997年 | 781篇 |
1996年 | 700篇 |
1995年 | 612篇 |
1994年 | 514篇 |
1993年 | 403篇 |
1992年 | 980篇 |
1991年 | 820篇 |
1990年 | 779篇 |
1989年 | 787篇 |
1988年 | 651篇 |
1987年 | 581篇 |
1986年 | 544篇 |
1985年 | 468篇 |
1984年 | 317篇 |
1983年 | 269篇 |
1982年 | 139篇 |
1981年 | 128篇 |
1979年 | 233篇 |
1978年 | 140篇 |
1977年 | 119篇 |
1974年 | 142篇 |
1973年 | 139篇 |
1972年 | 138篇 |
1971年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Donato Gemmati Alessia Ongaro Gian L Scapoli Matteo Della Porta Silvia Tognazzo Maria L Serino Eros Di Bona Francesco Rodeghiero Giuseppe Gilli Roberto Reverberi Angelo Caruso Michela Pasello Agnese Pellati Monica De Mattei 《Cancer epidemiology, biomarkers & prevention》2004,13(5):787-794
Folate and methionine metabolism is involved in DNA synthesis and methylation processes. Polymorphisms in the genes of folate metabolism enzymes have been associated with some forms of cancer. In a case-control study, we evaluated whether four common polymorphisms in methylenetetrahydrofolate reductase (MTHFR C677T and A1298C), methionine synthase (MS A2756G), and methionine synthase reductase (MTRR A66G) genes may have a role in altering susceptibility to adult acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL). We analyzed DNA of 120 adult ALL, 200 NHL, and 257 healthy control subjects. Individual carrying the MTHFR 677TT genotype showed a 3.6-fold decreased ALL risk [odds ratio (OR) 0.28, 95% confidence interval (95% CI) 0.12-0.72] than wild-types. Similarly, MS 2756GG individuals showed a 5.0-fold decreased ALL risk (OR 0.20, 95% CI 0.02-1.45) than wild-types. In combined results, subjects with the MTHFR 677CT/TT and MS 2756AG/GG genotypes revealed a 3.6-fold ALL risk reduction (OR 0.28, 95% CI 0.14-0.58) and those with the MTHFR 677TT and MTRR 66AG genotypes revealed a 4.2-fold ALL risk reduction (OR 0.24, 95% CI 0.06-0.81). Finally, those with the MS 2756AG/GG and MTRR 66AG/GG genotypes revealed a 2.2-fold ALL risk reduction (OR 0.45, 95% CI 0.10-0.85). Single analysis for NHL did not show any significant difference for all the polymorphisms investigated, but in the low-grade NHL subgroup, we found a 2.0-fold risk reduction for the MTRR 66GG homozygous genotype (OR 0.50, 95% CI 0.25-0.99), which was higher (OR 0.37, 95% CI 0.14-0.85) when analyzed in combination with MS 2756AA genotype. These data are in accordance with the hypothesis that polymorphisms in the genes for folate and methionine metabolism might play a greater role in the occurrence of ALL than NHL by influencing DNA synthesis and/or DNA methylation. 相似文献
992.
Di Paolo S Schena A Morrone LF Manfredi G Stallone G Derosa C Procino A Schena FP 《Transplantation》2000,69(10):2049-2054
BACKGROUND: In rodents, CsA has been shown to affect T-cell development, giving rise to an abnormal production of mature T cells and the absence of many T-cell subsets as well as to autoimmunity. Surprisingly, only a few studies investigated the effect of the immunosuppressive drug on the immune system of the human fetus. METHODS: We examined six infants born to female kidney transplant recipients who had received cyclosporine and methylprednisolone throughout their pregnancies. Peripheral blood was obtained 1 day and 2, 4, 6, and 12 months after birth, and two-color flow cytometric immunophenotyping of lymphocytes was performed. RESULTS: Total T cells, as well as CD4+ and CD8+ T cells, were low at birth, but normalized thereafter. Among T-cell activation markers, the expression of CD25, the alpha chain of the interleukin-2 receptor, was below the normal range or low range throughout the study period, and HLA-DR expression was extremely low at birth and failed to increase up to 12 months. The number of total B cells was lower than normal at birth, but steeply increased over time. In contrast, B-cell subset bearing CD5 antigen was severely depleted throughout the first year of life. Total IgG concentration was significantly lower than in controls at 2 months, mainly because of subnormal levels of IgG1 and IgG3 subclasses, which remained in the low range up to 6 months. Finally, infants showed normal numbers of true natural killer (NK) cells (CD3-CD16+CD56+), whereas the expression of CD57 antigen, defining non-MHC-restricted cytotoxic lymphocytes, was barely detectable at birth and failed to increase over time, in both CD8+ and CD8- subsets. Of note, none of the infants had clinical evidence of an immunodeficient state. CONCLUSIONS: continuous exposure to CsA in utero seemingly impairs T-, B-, and NK-cell development and/or maturation, and most of its effects are still apparent at 1 year, which might suggest that conventional vaccinations should be delayed in these infants. 相似文献
993.
目的 探讨银环蛇毒素及其若干组分在体外对白血病K562细胞株的凋亡诱导作用。方法 采用阳离子交换层析法分离纯化银环蛇粗毒,应用MTT法、荧光显微镜和流式细胞术等研究毒素对K562细胞株的凋亡作用。结果 除Ⅳ峰毒素外,银环蛇粗毒及分离的部分组分IV峰、Ⅶ峰和Ⅷ峰等毒素的荧光显微图末见特征性的凋亡小体,DNA含量分布组方图中的二倍体峰前末见Gl细胞群。结论 银环蛇毒对K562细胞具有杀伤作用,但并非是细胞凋亡作用,而是致细胞坏死,而粗毒中的某些组分可能具有促K562细胞凋亡作用。 相似文献
994.
PRINCIPAL CARDIOVASCULAR COMPLICATIONS IN END STAGE RENAL DISEASE: Cardiovascular diseases are the leading causes of morbidity and mortality in end stage renal disease patients. Very often, complications observed are left ventricular hypertrophy and various forms of arterial degenerative lesions involving coronary arteries, less frequently pericarditis and calcifying valvulopathy are diagnosed. THE REASONS ARE COMPLEX: Risk factors can be either specific of uremia per se such as anemia, overhydration, fistula or the same as in the general population. Hemodynamic alterations including tensile stress or blood flow play a major role associated to various locally or generally generated substances whose role remains currently to be determined. THEIR TREATMENTS: Treatments of cardiovascular complications are not specific in this end stage renal disease population but are more often the treatment of the etiology: reduction of fistula blood flow, increase of hemoglobin, best control of weight gain between two hemodialysis sessions or blood pressure control. 相似文献
995.
996.
Guglielmo Nasti Renato Talamini Andrea Antinori Ferdinando Martellotta Gaia Jacchetti Francesco Chiodo Giuseppe Ballardini Laura Stoppini Giovanni Di Perri Maurizio Mena Marcello Tavio Emanuela Vaccher Antonella D'Arminio Monforte Umberto Tirelli 《Journal of clinical oncology》2003,21(15):2876-2882
PURPOSE: To assess potential new prognostic factors and to validate the AIDS Clinical Trials Group (ACTG) for AIDS-related Kaposi's sarcoma (AIDS-KS) staging system in the highly active antiretroviral therapy (HAART) era. PATIENTS AND METHODS: We collected epidemiologic, clinical, staging, and survival data from 211 patients with AIDS-KS enrolled in two prospective Italian human immunodeficiency virus (HIV) cohort studies. We included in the analysis all patients with the diagnosis of KS made from January 1996, the time at which HAART became available in Italy. RESULTS: In the univariate analysis, survival was not influenced by sex, age, level of HIV viremia at KS diagnosis, HAART at KS diagnosis (HAART-na?ve v HAART-experienced), or type of HAART combination. Regarding ACTG classification, the 3-year survival rate was 85% for T0 patients and 69% for T1 patients (P =.007), 83% for S0 patients and 63% for S1 patients (P =.003), and 83% for I0 patients and 71% for I1 patients (P =.06). In the multivariate analysis, only the combination of poor tumor stage (T1) and poor systemic disease (S1) risk identified patients with unfavorable prognosis. The 3-year survival rate of patients with T1S1 was 53%, which was significantly lower compared with the 3-year survival rates of patients with T0S0, T1S0, and T0S1, which were 88%, 80%, and 81%, respectively (P =.0001). CONCLUSION: In the era of HAART, a refinement of the original ACTG staging system is needed. CD4 level does not seem to provide prognostic information. Two different risk categories are identified: a good risk (T0S0, T1S0, T0S1) and a poor risk (T1S1). 相似文献
997.
Franca Formelli Tiziana Camerini Elena Cavadini Valentina Appierto Maria Grazia Villani Alberto Costa Giuseppe De Palo Maria Gaetana Di Mauro Umberto Veronesi 《Cancer epidemiology, biomarkers & prevention》2003,12(1):34-41
OBJECTIVES: To assess, in women participating in a breast cancer prevention trialon fenretinide (4-HPR), the relationship of drug and retinol levels with the risk of second breast malignancy, taking into account age and menopausal status. METHODS: In a multicenter prevention trial, women with early breast cancer were randomly assigned to receive no treatment or 200 mg of 4-HPR/day for 5 years. Blood was collected at baseline and on a yearly basis during intervention from women recruited at the Istituto Tumori (Milan, Italy; 818 and 756 in the 4-HPR and control arm, respectively, who accounted for 53% of the participants in the trial). The plasma concentrations of 4-HPR, its main metabolite N-(4-methoxyphenyl) retinamide, and retinol were assayed by high-performance liquid chromatography. Three age ranges (or=56 years), menopausal status at baseline, and disease outcome at a median follow-up of 97 months were taken into account in the analysis. RESULTS: Baseline retinol levels were significantly lower (P or=46 years versus or= 0.71; P 相似文献
998.
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. 总被引:1,自引:0,他引:1
999.
谷胱苷肽转移酶抑制剂高通量筛选模型的建立和初步应用 总被引:1,自引:2,他引:1
谷胱苷肽 - S-转移酶 -π( GST-π)的活性在某些类型的癌症患者中有显著的升高并且在癌症细胞对抗癌药物抗药性的形成过程中起着重要的作用。抑制过量表达的 GST-π酶的活性将有助于克服肿瘤细胞的耐药性 ,因此 ,GST-π被认为是一个潜在的药物作用的靶位点。为了筛选新的抗癌药物的增敏剂 ,我们建立了一个 GST-π酶抑制剂的高通量筛选模型 ,该模型以 CDNB和 GSH为底物 ,在 96 -孔板上通过对 340 nm处吸光度的变化来检测样品对 GST-π酶的抑制活性。经过初筛和复筛 ,从 4 80 0个微生物发酵提取物中筛选到10个阳性样品 ,阳性率为 0 .2 %。 相似文献
1000.
目的 :为我国医药企业产品的品牌定位提供参考。方法 :简述医药产品品牌定位的涵义及其基础 ,提出医药产品品牌定位的策略。结果与结论 :在市场细分化、消费个性化的今天 ,医药产品的品牌定位是否成功 ,直接关系到企业的生存与发展 相似文献